Treatment

zagociguat 30mg clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE2
A Phase 2b Study of Zagociguat in Patients With MELAS
This study is testing a new medicine, zagociguat, for people with MELAS syndrome. It aims to see if the medicine can help with tiredness and thinking abilities, and if it's safe. Participants will take either the medicine or a dummy pill over two 12-week periods.
For: Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
United States · Australia · Canada